Printer Friendly

Iowa State, Monsanto to collaborate on soybean technologies.

The Iowa State University Research Foundation (Ames, IA) and Monsanto Company (St. Louis, MO) agreed to resolve a patent dispute related to low linolenic soybeans and establishes a relationship that paves the way for future technology development.

Under the terms of the agreement Monsanto will receive a commercial license from ISURF for current and future low linolenic acid product lines developed by Iowa State University. The University will receive a research license for the use of Roundup RReady2Yield soybeans. Additional terms of the agreement were not disclosed.

"This collaborative agreement will ensure that farmers will be able to obtain the benefits of these new soybean technologies delivered together in the seed," said Robb Fraley, Monsanto's chief technology officer. "We have had a long, productive relationship with Iowa State University and we look forward to working with them to provide ways for farmers to increase profitability and productivity and for consumers to get benefits from improved soybean oils."

Iowa State University President Gregory Geoffroy said, "The University and the Research Foundation are pleased with this agreement. We look forward to continuing our work with Monsanto for the benefit of the University, the company and farmers."

Soybeans that contain low linolenic acid content result in more stable oil that does not require hydrogenation. By eliminating hydrogenation, the oil has no trans fat. As additional soybean quality traits are developed by Iowa State, Monsanto's Roundup RReady2Yield trait will be made available for stacked combinations.

Monsanto is a leading global provider of technology-based solutions and agricultural products that improve farm productivity and food quality.

ISURF is a not-for-profit corporation that manages intellectual property arising from research carried out at Iowa State University.

Monsanto Company


Iowa State University

COPYRIGHT 2007 Biotech Patent News
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2007 Gale, Cengage Learning. All rights reserved.

Article Details
Printer friendly Cite/link Email Feedback
Publication:BIOTECH Patent News
Date:Aug 1, 2007
Previous Article:CODA Genomics announces issuance of optimized synthetic gene production patent.
Next Article:Oncolytics Biotech announces issuance of 23rd United States patent.

Related Articles
How big will it grow? The fortunes of Roundup Ready corn.
A new agreement between Monsanto Co., the University of Illinois and the USDA's Agricultural Research Service (ARS) is expected to generate a greater...
The Monsanto miracle: innovation nets big results.
Bayer CropScience and Monsanto enter long-term business and license agreements for key enabling technologies agreements creating new choices and more...
Monsanto establishes a global seed treatment platform where it will identify new proprietary seed-based technologies that can be launched in parallel...
Rhylander named NAMA marketer of the year.
Monsanto's R&D pipeline delivers innovation, value to farmers.
Syngenta reaches a definitive agreement with Monsanto which settles all outstanding litigation relating to the two companies' global corn and soybean...
BASF and Monsanto sign an exclusive agreement for a new fungicide seed treatment solution for soybeans in the U.S.

Terms of use | Privacy policy | Copyright © 2019 Farlex, Inc. | Feedback | For webmasters